A 70 anni dalla prima edizione, si terrà a Barcellona, dal 26 al 29 agosto prossimi, il congresso della Società europea di cardiologia (Esc), in versione ibrida, ovvero residenziale e on line. Dal vasto programma, abbiamo selezionato una serie di appuntamenti interessanti digitando sul motore di ricerca le parole chiave “Dietary supplements”, che vi segnaliamo:

26 Agosto

ore 9,15

Sessione: Prevention - Exercise

Relazione: Omega 3 fatty acid supplementation improves physical performance: a systematic review and meta-analysis of RCTs

Maciej Banach (Medical University of Lodz - Lodz, Poland) 

Ore 14:00

Sessione: Latest science in primary and secondary prevention and environmental health

Relazione: Effects of aspirin and omega−3 fatty acid supplements on heart failure in the ASCEND study

Michelle Goonasekera (University of Oxford - Oxford, United Kingdom of Great Britain & Northern Ireland)

ore 16:15

Sessione: Nutrition, malnutrition and heart disease

Relazioni:

• Serum magnesium is associated with long-term survival of non-ST-elevation myocardial infarction patients

Michael Shechter (Chaim Sheba Medical Center - Ramat Gan, Israel)

• Associations of dietary macronutrient composition with cardiometabolic health: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2014

Nicholas Koemel (The University of Sydney - New South Whales, Australia) 

• Selenium concentration and cardiovascular disease risk: Mendelian randomization study

                    Shuai Yuan (Karolinska Institute - Stockholm, Sweden) 

• Effects of omega-3 fatty acid supplementation on the risk of atrial fibrillation (AF) and micro-AF in the OMEMI trial

Peder Langeland Myhre (Akershus University Hospital - Akershus, Norway) 

• Effects of omega-3 fatty acids on dementia and cognitive Impairment in the ASCEND trial

Marion Mafham (Clinical Trial Service Unit University of Oxford - Oxford, United Kingdom of Great Britain & Northern Ireland)

• Trimethylamine N-oxide is associated with impaired cognitive function in patients with atrial fibrillation

Thea Ziswiler (Cantonal Hospital of Baden - Baden, Switzerland)

• Prognostic cut-off values of caffeine and cardiovascular events in a cohort of unselected men and women from general population

          Nicole Lievore (Padova, Italy)

28 Agosto

8,15

Sessione: Coronary artery disease - Pharmacotherapy 2

Relazione: The effect of vitamin k2 supplementation on coronary artery disease in a randomized multicenter trial

Selma Hasific (Odense University Hospital - Odense, Denmark)

12,15

Sessione: A journey through vascular diseases

Relazione: The effect of distinct dietary interventions on proximal aortic stiffness; the DIRECT-PLUS randomized controlled trial

Gal Tsaban (Soroka University Medical Center - Beer Sheva, Israel) 

 29 Agosto

8:30

Sessione: Blood pressure targets: reasonable and achievable. Joint with the Chinese Society of Cardiology (CSC)

Relazione: Dietary and lifestyle measures in the treatment of hypertension

Yangfeng Wu (Peking University - Beijing, China)

Ore 14

Sessione: Recent features from The Lancet. Joint with The Lancet

Relazioni:

• Reduction of dietary sodium to less than 100mmol in heart failure (SODIUM-HF).

                    Justin Ezekowitz (University of Alberta - Edmonton, Canada) 

• Long-term prevention of cardiovascular disease with a Mediterranean diet (CORDIOPREV).

          Javier Delgado-Lista (University of Cordoba - Cordoba, Spain)

Ore 16:45

Sessione: Individual treatment strategies in atrial fibrillation

Relazione: Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis

Hyojeong Ahn (Seoul National University Hospital - Seoul, Korea)

Tecnicamente si definisce crosstalk osteo-vascolare e indica uno stretto legame tra azione sulle ossa e a livello dei vasi. Questa una delle caratteristiche peculiari della vitamina K2 in grado di regolare il cosiddetto paradosso del calcio e mantenerne le giuste concentrazioni nei due diversi distretti.

Ne abbiamo parlato con Domitilla Mandatori, del Centro studi e tecnologie avanzate (Cast) all’Università G. d’Annunzio di Chieti e prima firma di una review da poco pubblicata su Nutrients.

I benefici cardiovascolari della vitamina K potrebbero dipendere non dalla forma k1 (fillochinone) ma dalla K2 (menachinone). Questo quanto sostenuto da un gruppo di ricercatori olandesi, britannici e francesi che hanno raccolto ed esaminato dati da un pool di poco più di 100 mila persone affette da cardiopatia afferenti a tre database: European prospective investigation into cancer and nutrition (Epic)-Cvd case-cohort study; CardiogramplusC4D a Uk Biobank.